JMP Securities initiated coverage on shares of U.S. Physical Therapy (NYSE:USPH – Free Report) in a report released on Monday morning, MarketBeat.com reports. The firm issued an outperform rating and a $113.00 target price on the stock.
Other equities research analysts have also issued reports about the stock. JPMorgan Chase & Co. boosted their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price target for the stock from $100.00 to $115.00 in a research report on Monday. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $114.00.
Read Our Latest Research Report on U.S. Physical Therapy
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 annualized dividend and a yield of 1.84%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.
Insider Transactions at U.S. Physical Therapy
In related news, insider Eric Joseph Williams sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the sale, the insider now directly owns 14,814 shares of the company’s stock, valued at approximately $1,419,773.76. This trade represents a 11.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,412 shares of company stock worth $706,605 over the last quarter. 1.70% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy during the second quarter valued at about $28,000. Innealta Capital LLC acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $30,000. Quest Partners LLC lifted its stake in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after purchasing an additional 337 shares in the last quarter. Quarry LP grew its holdings in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares during the period. Finally, Ridgewood Investments LLC acquired a new stake in U.S. Physical Therapy during the 2nd quarter worth approximately $51,000.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- What is Put Option Volume?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- What is the NASDAQ Stock Exchange?
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.